Skip to main content
. 2000 Sep 1;20(17):6666–6671. doi: 10.1523/JNEUROSCI.20-17-06666.2000

Fig. 4.

Fig. 4.

Statistically significant (*) induction of Fos in the infralimbic/ventral prelimbic cortex by the D3antagonist U-99194A demonstrating the neurobiological efficacy of this dose of U99194A in the present study. Fos immunoreactivity refers to the number of Fos-positive cells per mm2. VEH, Vehicle;U991, the selective D3 antagonist U99194A (16 mg/kg).